Skip to main content
Fig. 6 | Human Genomics

Fig. 6

From: Comprehensive analysis of alternative splicing across multiple transcriptomic cohorts reveals prognostic signatures in prostate cancer

Fig. 6

Performance of event-based signature across various datasets. Kaplan–Meier (KM) curves for biochemical recurrence-free survival (BCRFS) in low- and high-risk prostate cancer (PCa) patient groups. Curves are differentiated based on the six prognostic alternative splicing (AS) event signature risk score. These curves are presented for a the training set from The Cancer Genome Atlas Prostate Adenocarcinoma (TCGA-PRAD), b the testing set, c the entire set, and d the GSE107299 cohort. Time-dependent receiver operating characteristic (ROC) curves evaluate the performance of the six-event signature for predicting 3-, 5-, and 8-year BCRFS in e the TCGA-PRAD training set, f the testing set, g the complete set, and h the GSE107299 cohort

Back to article page

Human Genomics

ISSN: 1479-7364